These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15814242)

  • 21. Effervescent dry powder for respiratory drug delivery.
    Ely L; Roa W; Finlay WH; Löbenberg R
    Eur J Pharm Biopharm; 2007 Mar; 65(3):346-53. PubMed ID: 17156987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.
    Hadinoto K; Zhu K; Tan RB
    Int J Pharm; 2007 Aug; 341(1-2):195-206. PubMed ID: 17467934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.
    Jones MD; Harris H; Hooton JC; Shur J; King GS; Mathoulin CA; Nichol K; Smith TL; Dawson ML; Ferrie AR; Price R
    Eur J Pharm Biopharm; 2008 Jun; 69(2):496-507. PubMed ID: 18191553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H; Markefka P; teWierik H; Kammelar R
    Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The adhesive strength of non-spherical particles mediated by specific interactions.
    Decuzzi P; Ferrari M
    Biomaterials; 2006 Oct; 27(30):5307-14. PubMed ID: 16797691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactose as a carrier for inhalation products: breathing new life into an old carrier. Preface.
    Marriott C; Frijlink HW
    Adv Drug Deliv Rev; 2012 Mar; 64(3):217-9. PubMed ID: 22146699
    [No Abstract]   [Full Text] [Related]  

  • 27. Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats.
    Karathanasis E; Bhavane R; Annapragada AV
    J Control Release; 2006 Jun; 113(2):117-27. PubMed ID: 16765471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly loaded interactive mixtures for dry powder inhalers: prediction of the adhesion capacity using surface energy and solubility parameters.
    Wagner KG; Dowe U; Zadnik J
    Pharmazie; 2005 May; 60(5):339-44. PubMed ID: 15918581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of a bioadhesive drug delivery system targeted to oesophageal tissue.
    Batchelor HK; Tang M; Dettmar PW; Hampson FC; Jolliffe IG; Craig DQ
    Eur J Pharm Biopharm; 2004 Mar; 57(2):295-8. PubMed ID: 15018987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of evaporation of primer components on ultimate tensile strengths of primer-adhesive mixture.
    Ikeda T; De Munck J; Shirai K; Hikita K; Inoue S; Sano H; Lambrechts P; Van Meerbeek B
    Dent Mater; 2005 Nov; 21(11):1051-8. PubMed ID: 16140370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proniosomal powder of captopril: formulation and evaluation.
    Gupta A; Prajapati SK; Singh M; Balamurugan M
    Mol Pharm; 2007; 4(4):596-9. PubMed ID: 17472398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scanning white-light interferometry as a novel technique to quantify the surface roughness of micron-sized particles for inhalation.
    Adi S; Adi H; Chan HK; Young PM; Traini D; Yang R; Yu A
    Langmuir; 2008 Oct; 24(19):11307-12. PubMed ID: 18759384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of dose on the performance of dry powder inhalation systems.
    Young PM; Edge S; Traini D; Jones MD; Price R; El-Sabawi D; Urry C; Smith C
    Int J Pharm; 2005 May; 296(1-2):26-33. PubMed ID: 15885452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dry powder inhaler formulation.
    Telko MJ; Hickey AJ
    Respir Care; 2005 Sep; 50(9):1209-27. PubMed ID: 16122404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheological studies on pressure-sensitive silicone adhesives and drug-in-adhesive layers as a means to characterise adhesive performance.
    Ho KY; Dodou K
    Int J Pharm; 2007 Mar; 333(1-2):24-33. PubMed ID: 17049768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug content effects on the dispersion performance of adhesive mixtures for inhalation.
    Grasmeijer F; Hagedoorn P; Frijlink HW; de Boer AH
    PLoS One; 2013; 8(8):e71339. PubMed ID: 23967195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids.
    Hadinoto K; Phanapavudhikul P; Kewu Z; Tan RB
    Int J Pharm; 2007 Mar; 333(1-2):187-98. PubMed ID: 17084567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.